Latest News
Adaptive Biotechnologies Corporation
- Form 4 Adaptive Biotechnologies Corp: Julie Rubinstein (President and COO) For: 19 October
- Adaptive Biotechnologies president and coo Julie Rubinstein sells $879,088 in shares
- Adaptive Biotechnologies Sets November 4 Date for Q3 2026 Results
- Adaptive Biotechnologies to report Q3 2026 earnings on November 4, with a webcast for investors.
- Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026
- Form 144 ADAPTIVE BIOTECHNOLOGIES CORPORATION For: 11 October By Investing.com
- Form 4 Adaptive Biotechnologies Corp For: 8 October By Investing.com
- Form 4 Adaptive Biotechnologies Corp For: 5 October By Investing.com
- Adaptive Biotechnologies stock hits 52-week high at $30.10 By Investing.com
- Form 4 Adaptive Biotechnologies Corp For: 28 September By Investing.com
- Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
- Adaptive Biotechnologies stock hits 52-week high at 28.79 USD By Investing.com
Headlines from the last 30 days, linking to the original publishers. See all market news →